Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06843512

Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication

Exploring the Influence of GLP-1 Medication on Food Attitudes and Selection in a Virtual Reality Buffet

Status
Recruiting
Phase
Study type
Observational
Enrollment
25 (estimated)
Sponsor
Penn State University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and amounts of foods an individual will choose. The purpose of this study is to observe the changes an individual experiences in their relationship and reaction to food and in their food selection prior to or within the first two weeks of taking GLP-1 medication to after three months on the medication. The researchers of this study believe that an understanding of such changes can inform questions seeking to ensure maintenance of appropriate nutrient balance within individuals on weight loss medications.

Conditions

Interventions

TypeNameDescription
OTHERGLP-1 Medication InitiationOne visit before starting GLP-1 medication and one visit 3 months after. No other changes administered between visits.

Timeline

Start date
2025-07-15
Primary completion
2026-12-01
Completion
2026-12-01
First posted
2025-02-25
Last updated
2025-09-10

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT06843512. Inclusion in this directory is not an endorsement.